Skip to main content
Caplight Logo









MIVI Neuroscience

MIVI Neuroscience

Private
Eden Prairie, MinnesotaHealthcare & Life Scienceshttps://mivineuro.com/

Last Round

Debt

May 15, 2024

Total Funding Raised

$87.64M

Company Overview

MIVI Neuroscience is a healthcare company that develops and commercializes innovative clinical solutions and medical devices for neuro-interventional procedures to improve stroke treatment outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurointerventional devicesaspiration catheterthrombectomy systemstroke interventionmechanical thrombectomyneurovascular devicesclot retrievalrevascularizationguide catheterischemic stroke treatmentneurointerventionendovascular therapystroke hardwareinterventional neuroradiologymedical device sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MIVI Neuroscience Comparables

Compare MIVI Neuroscience with similar companies based on industry and business-model similarity.

MIVI Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perfuze
90%
Q'Apel Medical
88%
RapidPulse
88%

MIVI Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 15, 2024
Series BJan 21, 2021
Series AMar 19, 2020
Series AMay 14, 2019
SeedSep 7, 2017
Seed
Mar 17, 2017

MIVI Neuroscience Investors

Notable investors and investment history

MIVI Neuroscience investors
InvestorRounds
Deerfield ManagementSeries B
Aphelion CapitalSeries B
Perceptive AdvisorsSeries B
Concord Health PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2024

    $9.25M debt round completed.

  • Mar 19, 2020

    $20M round completed.

MIVI Neuroscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MIVI Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MIVI Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersEden Prairie, Minnesota
Year Founded2013
Last FundingMay 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?